Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 23Breast Neoplasms 22Carcinoma, Non-Small-Cell Lung 17Rectal Neoplasms 13Prostatic Neoplasms 13Gliosarcoma 12Lung Neoplasms 10Head and Neck Neoplasms 10Esophageal Neoplasms 10Brain Neoplasms 10Neoplasms 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Adenocarcinoma Of Esophagus 8Sarcoma 7Neoplasm Metastasis 7Central Nervous System Neoplasms 7Pancreatic Neoplasms 6Melanoma 6Glioma 6Carcinoma, Squamous Cell 6Astrocytoma 6Urinary Bladder Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Oropharyngeal Neoplasms 4Medulloblastoma 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 4pembrolizumab 3napabucasin 3Paclitaxel 3Irinotecan 3selpercatinib 2pralsetinib 2patritumab 2Standard of Care 2Pemetrexed 2Nivolumab 2Fluorouracil 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Ascorbic Acid 2Albumin-Bound Paclitaxel 2valrubicin 1sotorasib 1ribociclib 1relatlimab 1pamiparib 1osimertinib 1ipatasertib 1durvalumab 1dostarlimab 1cobimetinib 1atezolizumab 1alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms by Site × Radiation × Clear all
NCT03150862 2025-02-04

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

BeiGene

Phase 1/2 Completed
116 enrolled 31 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡